Cytel is confirmed as a finalist in Most Innovative Trial Design and Best Sponsor-focused Technological Development categories at the Informa Clinical and Research Excellence Awards. The awards recognize innovation and excellence in the biopharma industry and Cytel is recognized for developments on East 6.4 and a innovative trial design created for sponsor Tracon Pharmaceuticals. The winners will be announced in April.
